RTSN insider trading
Retension Pharmaceuticals, Inc.: insider trade history from SEC Form 4 filings.
RTSN insider activity at a glance
FilingIQ tracks 12 insider transactions for RTSN in filings since Oct 13, 2026. The most recent transaction is dated Oct 13, 2026.
Across the full history, 2 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on RTSN insider trades is 56.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest RTSN Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Frequently asked
- How many insider trades does FilingIQ track for RTSN?
- FilingIQ tracks 12 Form 4 insider transactions for RTSN (Retension Pharmaceuticals, Inc.), covering filings from Oct 13, 2026 onwards. 12 of those are dated within the last 90 days.
- Are RTSN insiders net buyers or net sellers?
- Across the full Form 4 history for RTSN, 2 transactions (17%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does RTSN insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
Methodology & sources
Every RTSN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.